Former Centers for Disease Control and Prevention Director Dr. Robert Redfield appeared Wednesday on Newsmax to discuss Dr.

T he Brutalist director Brady Corbet is hopeful that the success of his historical epic, which stars Adrien Brody as ...

In summary, Oppenheimer's latest comments on Tesla (NASDAQ:TSLA) reflect a cautious but watchful stance on the company's ...

SentinelOne Inc (S) stock saw a modest uptick, ending the day at $23.22 which represents a slight increase of $0.49 or 2.16% from the prior close of $22.73. The stock opened at $23 and touched a low ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Viking Therapeutics Inc.’s stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company’s promising ...

Casting rumors for the Harry Potter TV reboot have been heating up over the past few months, with plenty of names for Snape ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Notably, analysts at Oppenheimer consider Nvidia as the chip stock to own for 2025. In a client note, Oppenheimer highlighted ...

R Madhavan about his working philosophies, his disappointment with recent Hollywood films including Christopher Nolan’s ...

EXCLUSIVE: Christopher Nolan ’s adaptation of The Ody ssey is adding to its already stellar cast as sources tell Deadline ...

Jay Olson, an analyst from Oppenheimer, maintained the Buy rating on Viking Therapeutics (VKTX – Research Report). The associated price target ...